| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/05/2006 | EP1556467B1 Use of metal complex compounds as oxidation catalysts |
| 07/05/2006 | EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 07/05/2006 | EP1280794B1 Diazacycloalkane derivatives as bleach catalyst and composition and method for bleaching a substrate |
| 07/05/2006 | EP1225894B1 Fab i inhibitors |
| 07/05/2006 | EP1039905B1 Pharmaceutical formulation comprising glycine as a stabilizer |
| 07/05/2006 | CN1798744A 3-fluoro-piperidines as NMDA/NR2B antagonists. |
| 07/05/2006 | CN1798740A Nitrogen-containing heteroaryl derivatives |
| 07/05/2006 | CN1798738A Biaryl substituted pyrazoles as sodium channel blockers |
| 07/05/2006 | CN1798737A Composition, process of making, and medical use of substituted 4-phenyltetrahydroisoquinolines |
| 07/05/2006 | CN1798735A 1-aryl-4-(aryloxycarbonyl)-piperazine derivatives for use as inhibitors of hormone sensitive lipase |
| 07/05/2006 | CN1798734A Novel compounds and compositions as protein kinase inhibitors |
| 07/05/2006 | CN1798726A Substituted indoles and a process for preparing substituted indoles |
| 07/05/2006 | CN1798559A Quinoline-2-one-derivatives for the treatment of airways diseases |
| 07/05/2006 | CN1262541C Tricyclic protein kinase inhibitors |
| 07/05/2006 | CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods |
| 07/04/2006 | US7071337 Anticancer agents |
| 07/04/2006 | US7071335 2-pyridinyl-1-piperazine therapeutic agents useful for treating pain |
| 07/04/2006 | US7071332 Indolinone derivatives as protein kinase/phosphatase inhibitors |
| 07/04/2006 | US7071218 N-substituted heterocycles for the treatment of hypercholesteremia, dyslipidemia and other metabolic disorders; cancer, and other diseases |
| 07/04/2006 | US7071217 Substituted oxindole derivatives as tyrosine kinase inhibitors |
| 07/04/2006 | US7071216 Anticancer agents |
| 07/04/2006 | US7071215 Anthelmintic and insecticidal compositions |
| 07/04/2006 | US7071213 Cannabinoid receptor ligands |
| 07/04/2006 | US7071201 Serotonin antagonism; muscle relaxant for myotonia; such as 1-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-7-methoxy-1,2,3,4 -tetrahydroquinoline |
| 07/04/2006 | US7071200 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 07/04/2006 | US7071198 Antiinflamamtory agents; antiarthritic agents; inflammatory bowel disorders; multiple sclerosis; asthma |
| 07/04/2006 | US7071196 Piperazine derivatives as antagonists of tachykinins, including substance P and other neurokinins. |
| 07/04/2006 | US7071195 Especially amino- or amido-ethyltetralin derivatives |
| 07/04/2006 | US7071192 Respiratory system disorders; infections in infants |
| 07/04/2006 | US7071191 Non-imidazole aryloxypiperidines |
| 07/04/2006 | US7071184 Protease inhibitors |
| 07/04/2006 | US7071182 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor |
| 07/04/2006 | US7071180 Eating disorders; cognition activators; psychological disorders; anxiolytic agents; sexual disorders; incontinence; antidepressants |
| 07/04/2006 | CA2364719C 2-aminopyridines containing fused ring substituents |
| 07/04/2006 | CA2332066C Tetrazole compounds as thyroid receptor ligands |
| 06/29/2006 | WO2006069395A2 Synthetic process for the preparation of biocyclic compounds |
| 06/29/2006 | WO2006069208A2 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 06/29/2006 | WO2006069196A1 3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands |
| 06/29/2006 | WO2006068992A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/29/2006 | WO2006068991A1 Cycloalkyl lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/29/2006 | WO2006068904A1 Tetrahydroquinoline analogues as muscarinic agonists |
| 06/29/2006 | WO2006068617A1 A new manufacturing process for the preparation of halogen substituted 4-hydroxy-2-(2-chloro-4-methylphenyl)-1,2,5,10-tetrahydropyridazino[4,5-b]quinoline-1,10-dione |
| 06/29/2006 | WO2006068594A1 HETEROCYCLIC MCHr1 ANTAGONISTS AND THEIR USE IN THERAPY |
| 06/29/2006 | WO2006068213A1 Glycine derivative and use thereof |
| 06/29/2006 | WO2006068105A1 Therapeutic agent for keratoconjunctive disorder |
| 06/29/2006 | WO2006068102A1 2-(pyrazol-1-yl)pyridine derivative |
| 06/29/2006 | WO2006067976A1 Organic compound, charge-transporting material, and organic electroluminescent element |
| 06/29/2006 | WO2006067531A1 G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes |
| 06/29/2006 | WO2006067529A1 Piperidine and azetidine derivatives as glyt1 inhibitors |
| 06/29/2006 | WO2006067472A1 Parp inhibitors |
| 06/29/2006 | WO2006067466A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |
| 06/29/2006 | WO2006067462A1 1,6 - substituted (3r,6r) -3- (2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis |
| 06/29/2006 | WO2006067446A1 Pyridine carboxamide derivatives for use as anticancer agents |
| 06/29/2006 | WO2006067444A1 Amide derivatives |
| 06/29/2006 | WO2006067401A1 Heterocyclic compounds as ccr2b antagonists |
| 06/29/2006 | WO2006067391A1 Pyrazolylamino substituted quinazoles for the treatment of cancer |
| 06/29/2006 | WO2006067385A1 Chemical compounds |
| 06/29/2006 | WO2006067139A1 Triazolone, tetrazolone and imidazolone derivatives for use as alpha-2c adrenoreceptor antagonists |
| 06/29/2006 | WO2006066968A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 06/29/2006 | WO2006066948A1 Piperidine derivatives as antagonists of the cc chemokine receptor ccr1 and their use as anti-inflammatory agents |
| 06/29/2006 | WO2006066924A2 Azole derivatives with antimuscarinic activity |
| 06/29/2006 | WO2006066899A1 Novel thrombin inhibitors |
| 06/29/2006 | WO2006066896A2 Pyrrolidine derivatives for the treatment of a disease depending on the activity of renin |
| 06/29/2006 | WO2006066885A1 Substituted n-heterocyclic compounds and their use as dopamine d3 receptor ligands |
| 06/29/2006 | WO2006066879A2 Compounds with kv4 ion channel activity |
| 06/29/2006 | WO2006066584A1 Novel cyanoguanidine compounds |
| 06/29/2006 | WO2004047745A3 3-(pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openers |
| 06/29/2006 | US20060142612 Arylsulfonamide derivatives |
| 06/29/2006 | US20060142580 N-phenyl-2-pyrimidine-amine derivatives |
| 06/29/2006 | US20060142578 Novel process |
| 06/29/2006 | US20060142577 4-Diethylamino-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-3-(trifluoromethyl)-benzamide; disease which responds to an inhibition of protein kinase activity, especially a neoplastic disease; leukemia |
| 06/29/2006 | US20060142575 Hetereoaryl nitrile derivatives |
| 06/29/2006 | US20060142369 Delta 1-pyrrolines used as pesticides |
| 06/29/2006 | US20060142365 Benzimidazole compounds and antiviral uses thereof |
| 06/29/2006 | US20060142363 Imidazolidinedione analogs useful as anticoagulants and antithrombotics |
| 06/29/2006 | US20060142345 3,5 Disubstituted indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation |
| 06/29/2006 | US20060142342 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 06/29/2006 | US20060142341 Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives |
| 06/29/2006 | US20060142338 Androgen sensitive diseases; prostate cancer; skin disorders; alopecia |
| 06/29/2006 | US20060142336 N-sulfonylpiperidines as metalloproteinase inhibitors (tace) |
| 06/29/2006 | US20060142334 Tetrahydroquinoline derivatives |
| 06/29/2006 | US20060142333 e.g. N-(1-Methyl-1,2,3,4-tetrahydroquinolin-7-yl)-1,1'-biphenyl-4-carboxamide; capsaicin recepor antagonist; analgesic; neuropathic, postoperative, postrheumatoid arthritic, back, cancer pain, neuralgia, dental pain, headache, migraine, diabetic and HIV-related neuropathy |
| 06/29/2006 | US20060142332 5-HT7 receptor antagonists |
| 06/29/2006 | US20060142325 Fused bicyclic-substituted amines as histamine-3 receptor ligands |
| 06/29/2006 | US20060142323 Dual binding site acetylcholinesterase inhibitors for the treatment of alzheimer's disease |
| 06/29/2006 | US20060142314 2-substituted-4-(indazol-5-ylamino)-6,7-dimethoxyquinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142313 2-substituted-4-(indazolamino)quinazoline compounds; use treating hypertension, atherosclerosis, restenosis, cerebral ischemia or vasospasm, neurodegeneration, spinal cord injury, cancer, thrombotic disorders, asthma, glaucoma, osteoporosis or erectile dysfunction |
| 06/29/2006 | US20060142293 e.g. 4-[5-(Piperidine-1-carbonyl)-furan-2-ylmethyl]-2H-phthalazin-1-one; enzyme poly(ADP-ribose)polymerase (synthase)-1 or poly ADP-ribosyltransferase (PARP-1) inhibitor; anticarcinogenic agent with BRCA2 deficient phenotype; septic shock; ischemic injury; hemorrhagic shock; multiple sclerosis |
| 06/29/2006 | US20060142281 Indolinone derivatives |
| 06/29/2006 | DE102004060229A1 Neue zyklische Harnstoffe als Inhibitoren von Metallproteasen New cyclic ureas as inhibitors of metalloproteases |
| 06/29/2006 | CA2592442A1 Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 06/29/2006 | CA2592378A1 3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands |
| 06/29/2006 | CA2592170A1 Glycine derivative and use thereof |
| 06/29/2006 | CA2591983A1 Pharmaceutical compositions comprising amorphous benzimidazole compounds |
| 06/29/2006 | CA2591940A1 Azole derivatives with antimuscarinic activity |
| 06/29/2006 | CA2591922A1 G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes |
| 06/29/2006 | CA2591827A1 1,6 - substituted (3r,6r) -3- (2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis |
| 06/29/2006 | CA2591766A1 Tetrahydroquinoline analogues as muscarinic agonists |
| 06/29/2006 | CA2591705A1 Novel farnesyl protein transferase inhibitors as antitumor agents |
| 06/29/2006 | CA2591208A1 Pyrazines and pyridines and derivatives thereof as therapeutic compounds |